OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells

Molecular Pharmacology
Adly YacoubPaul Dent

Abstract

We determined one mechanism by which the putative phosphoinositide-dependent kinase (PDK)-1 inhibitor 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}acetamide (OSU-03012) killed primary human glioma and other transformed cells. OSU-03012 caused a dose-dependent induction of cell death that was not altered by p53 mutation, expression of ERBB1 vIII, or loss of phosphatase and tensin homolog deleted on chromosome 10 function. OSU-03012 promoted cell killing to a greater extent in glioma cells than in nontransformed astrocytes. OSU-03012 and ionizing radiation caused an additive, caspase-independent elevation in cell killing in 96-h viability assays and true radiosensitization in colony formation assays. In a cell type-specific manner, combined exposure to OSU-03012 with a mitogen-activated protein kinase kinase 1/2 inhibitor, phosphoinositide 3-kinase/AKT inhibitors, or parallel molecular interventions resulted in a greater than additive induction of cell killing that was independent of AKT activity and caspase function. OSU-03012 lethality as a single agent or when combined with signaling modulators was not modified in cells lacking expression of BIM or of BAX/BAK. OSU-03012 promoted the release of ...Continue Reading

References

Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Nov 14, 2000·The Journal of Biological Chemistry·V StokaG S Salvesen
Jan 5, 2001·Cancer Treatment Reviews·C NiederM Molls
Feb 26, 2003·Radiation Research·Paul DentRupert Schmidt-Ullrich
Aug 30, 2003·Oncogene·Paul DentSteven Grant
Dec 8, 2004·Current Medicinal Chemistry·W Kiefer, G Dannhardt
Feb 1, 2005·Anesthesiology·Gregory DemboEvan D Kharasch
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manish I PatelAndrew J Dannenberg
Jul 13, 2005·The Journal of Biological Chemistry·Kuntebommanahalli N ThimmaiahPeter J Houghton
Jul 27, 2005·Biochemical Society Transactions·K Kashfi, B Rigas
Oct 13, 2005·Current Opinion in Gastroenterology·Christopher J Hawkey, Paul J Fortun
Nov 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei CuiKe-Qin Hu

❮ Previous
Next ❯

Citations

Aug 28, 2010·Cell Death and Differentiation·S LépineS Spiegel
Oct 7, 2009·Antimicrobial Agents and Chemotherapy·Hao-Chieh ChiuChing-Shih Chen
Apr 12, 2012·Molecular Cancer Therapeutics·Neil E BholaJennifer R Grandis
Jun 8, 2007·Biological Chemistry·Veronika StokaBoris Turk
Jul 15, 2011·Clinical and Experimental Gastroenterology·Claire M PayneHarris Bernstein
Jan 31, 2008·Expert Opinion on Investigational Drugs·Axel H SchönthalNicos A Petasis
Dec 30, 2014·Journal of Cellular Physiology·Laurence BoothPaul Dent
Oct 11, 2014·Journal of Cellular Physiology·Laurence BoothPaul Dent
Sep 25, 2012·Biochemical Pharmacology·Axel H Schönthal
Apr 11, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tina X LeeLong-Sheng Chang
Jul 12, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Audrey D LafrenayeJohn T Povlishock
Jul 17, 2014·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Audrey D LafrenayeJohn T Povlishock
Jan 9, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Hans K Lorenzo, Santos A Susin
Sep 18, 2008·International Journal of Cancer. Journal International Du Cancer·Haiming DingSteven M D'Ambrosio
Mar 26, 2011·IUBMB Life·Laure DelavalléeSantos A Susin
Dec 9, 2014·Cancer Biology & Therapy·Laurence BoothPaul Dent
Mar 3, 2015·Journal of Dermatological Science·Makoto WadaNorito Katoh
Sep 20, 2012·Cancer Biology & Therapy·Laurence BoothPaul Dent
Feb 18, 2015·DNA and Cell Biology·Laurence BoothPaul Dent
Jul 1, 2011·International Journal of Cancer. Journal International Du Cancer·Lova SegerströmJohn Inge Johnsen
Jun 21, 2018·Cancer Biology & Therapy·Laurence BoothPaul Dent
May 6, 2006·Molecular Pharmacology·James A McCubreyRichard A Franklin
Jul 14, 2010·Molecular and Cellular Biochemistry·Wei-Wen KuoChieh-Hsi Wu
Jul 16, 2014·Oncology Reports·Andres SilvaNaohiko Ikegaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.